These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 29118764)

  • 1. Folic Acid and Homocysteine in Chronic Kidney Disease and Cardiovascular Disease Progression: Which Comes First?
    Cianciolo G; De Pascalis A; Di Lullo L; Ronco C; Zannini C; La Manna G
    Cardiorenal Med; 2017 Oct; 7(4):255-266. PubMed ID: 29118764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The link between homocysteine, folic acid and vitamin B12 in chronic kidney disease.
    Angelini A; Cappuccilli ML; Magnoni G; Croci Chiocchini AL; Aiello V; Napoletano A; Iacovella F; Troiano A; Mancini R; Capelli I; Cianciolo G
    G Ital Nefrol; 2021 Aug; 38(4):. PubMed ID: 34469084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid attenuates hyperhomocysteinemia-induced glomerular damage in rats.
    Cao L; Lou X; Zou Z; Mou N; Wu W; Huang X; Tan H
    Microvasc Res; 2013 Sep; 89():146-52. PubMed ID: 23859838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine in Renal Injury.
    Long Y; Nie J
    Kidney Dis (Basel); 2016 Jun; 2(2):80-7. PubMed ID: 27536696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low doses of folic acid can reduce hyperhomocysteinemia-induced glomerular injury in spontaneously hypertensive rats.
    Gao N; Zhang Y; Lei L; Li L; Cao P; Zhao X; Lin L; Xu R
    Hypertens Res; 2020 Nov; 43(11):1182-1191. PubMed ID: 32439914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Controversial Role of HCY and Vitamin B Deficiency in Cardiovascular Diseases.
    Herrmann W; Herrmann M
    Nutrients; 2022 Mar; 14(7):. PubMed ID: 35406025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Roles of Aerobic Exercise and Folate Supplementation in Hyperhomocysteinemia-Accelerated Atherosclerosis.
    Zhong X; He R; You S; Liu B; Wang X; Mao J
    Acta Cardiol Sin; 2023 Mar; 39(2):309-318. PubMed ID: 36911543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid enhances the cardiovascular protective effect of amlodipine in renal hypertensive rats with elevated homocysteine.
    Li L; Tong X; Ma Z; Lv L; Liu H; Chen GL
    Clin Exp Hypertens; 2023 Dec; 45(1):2205058. PubMed ID: 37154141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of folate, vitamin B6, and vitamin B12 intake and MTHFR C677T polymorphism on homocysteine concentrations of renal transplant recipients.
    Biselli PM; Sanches de Alvarenga MP; Abbud-Filho M; Ferreira-Baptista MA; Galbiatti AL; Goto MT; Cardoso MA; Eberlin MN; Haddad R; Goloni-Bertollo EM; Pavarino-Bertelli EC
    Transplant Proc; 2007 Dec; 39(10):3163-5. PubMed ID: 18089344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine, cysteine, folate and vitamin B₁₂ status in type 2 diabetic patients with chronic kidney disease.
    Pastore A; Noce A; Di Giovamberardino G; De Stefano A; Callà C; Zenobi R; Dessì M; Di Daniele N
    J Nephrol; 2015 Oct; 28(5):571-6. PubMed ID: 25095762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Controversial Role of Homocysteine in Neurology: From Labs to Clinical Practice.
    Moretti R; Caruso P
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30626145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine and Hyperhomocysteinaemia.
    Zaric BL; Obradovic M; Bajic V; Haidara MA; Jovanovic M; Isenovic ER
    Curr Med Chem; 2019; 26(16):2948-2961. PubMed ID: 29532755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel approach in the management of hyperhomocysteinemia.
    Qureshi SS; Gupta JK; Goyal A; Narayan Yadav H
    Med Hypotheses; 2019 Aug; 129():109245. PubMed ID: 31371071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation inhibits NADPH oxidase-mediated superoxide anion production in the kidney.
    Hwang SY; Siow YL; Au-Yeung KK; House J; O K
    Am J Physiol Renal Physiol; 2011 Jan; 300(1):F189-98. PubMed ID: 20980407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients.
    Suliman ME; Lindholm B; Bárány P; Qureshi AR; Stenvinkel P
    Semin Dial; 2007; 20(6):523-9. PubMed ID: 17991198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular processes mediating hyperhomocysteinemia-induced metabolic reprogramming, redox regulation and growth inhibition in endothelial cells.
    Jan M; Cueto R; Jiang X; Lu L; Sardy J; Xiong X; Yu JE; Pham H; Khan M; Qin X; Ji Y; Yang XF; Wang H
    Redox Biol; 2021 Sep; 45():102018. PubMed ID: 34140262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of hyperhomocysteinemia.
    Herrmann W
    Clin Lab; 2006; 52(7-8):367-74. PubMed ID: 16955635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentration of homocysteine in spontaneous feline chronic kidney disease.
    Giraldi M; Paltrinieri S; Curcio C; Scarpa P
    Vet J; 2019 Dec; 254():105358. PubMed ID: 31836166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of homocysteine in protein quality control processes.
    Reddy VS; Trinath J; Reddy GB
    Biochimie; 2019 Oct; 165():19-31. PubMed ID: 31269461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid mitigates angiotensin-II-induced blood pressure and renal remodeling.
    Pushpakumar SB; Kundu S; Metreveli N; Sen U
    PLoS One; 2013; 8(12):e83813. PubMed ID: 24386282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.